ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $646,650 | -15.2% | 27,000 | -33.3% | 0.02% | -25.8% |
| Q1 2023 | $762,210 | -33.2% | 40,500 | -49.9% | 0.03% | -44.6% |
| Q2 2022 | $1,141,000 | +214.3% | 80,900 | +439.3% | 0.06% | +229.4% |
| Q1 2022 | $363,000 | +62.8% | 15,000 | +73.5% | 0.02% | +142.9% |
| Q1 2021 | $223,000 | -46.9% | 8,647 | -44.7% | 0.01% | -70.8% |
| Q1 2019 | $420,000 | -90.6% | 15,644 | -94.7% | 0.02% | -89.6% |
| Q2 2018 | $4,471,000 | – | 292,769 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |